You are using an older browser version. Please use a supported version for the best MSN experience.

Nitya Balasubramanian On India's Vaccine Challenges & IP Waiver Debate | Covid-19 Pandemic

India has administered 18 crore Covid vaccine doses with just a little over 3% of the total population fully vaccinated with two doses. Moreover, only less than 40 lakh have received their first jab in the 18-44 age group with vaccine shortages slowing down the process. To talk about India's vaccine challenges and IP waiver debate, we are joined in by Nitya Subramanian, Director of Stanford Bernstein.#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #Covid19Pandemic #NityaSubramanianCNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.For latest news and updates visit our Website: https://bit.ly/2YbpXBMSubscribe to our Channel: https://www.youtube.com/user/CNBCTV18Like us on Facebook: https://www.facebook.com/cnbctv18india/Follow us on Twitter: https://twitter.com/CNBCTV18News

UP NEXT

UP NEXT

More From CNBCTV18

More From CNBCTV18

image beaconimage beaconimage beacon